Severe jaundice following treatment with ezetimibe

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 6, 2008, Pages 572-573

  Ritchie, Stephen R ^a,b   Orr, David W ^b   Black, Peter N ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Adverse drug reaction; Cirrhosis; Ezetimibe

Indexed keywords

BILIRUBIN; EZETIMIBE;

ADULT; APPETITE; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER; PATIENT MONITORING; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT;

ANTICHOLESTEREMIC AGENTS; AZETIDINES; FATTY LIVER; FEMALE; HUMANS; HYPERBILIRUBINEMIA; JAUNDICE; MIDDLE AGED;

EID: 43449115386     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f1752d     Document Type: Article

References (7)

1. Stolk MF, Becx MC, Kuypers KC, Seldenrijk CA. Severe hepatic side effects of ezetimibe. Clin Gastroenterol Hepatol 2006; 4:908-911.
2. Kamisako T, Kobayashi Y, Takeuchi K, Ishihara T, Higuchi K, Tanaka Y, et al. Recent advances in bilirubin metabolism research: the molecular mechanism of hepatocyte bilirubin transport and its clinical relevance. J Gastroenterol 2000; 35:659-664.
3. Keitel V, Nies AT, Brom M, Hummel-Eisenbeiss J, Spring H, Keppler D. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 2003; 284:165-174.
4. Oswald S, Haenisch S, Fricke C, Sudhop T, Remmler C, Giessmann T, et al. Intestinal expression of p-glycoprotein (ABCB1), multidrug resistance associated protein 2 (ABCC2), and uridine diphosphate-glucuronosyltransferase 1A1 predicts the disposition and modulates the effects of the cholesterol absorption inhibitor ezetimibe in humans. Clin Pharmacol Ther 2006; 79:206-217.
5. Geier A, Dietrich CG, Grote T, Beuers U, Prüfer T, Fraunberger P, et al. Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. J Hepatol 2005; 43:1021-1030.
6. Gray CH. A critical review of changes in liver function during liver disease. QJM 1950; 76:263-276.
7. Gibson PR, Grant J, Cronin V, Blake D, Ratnaike S. Effect of hepatobiliary disease, chronic hepatitis C and hepatitis B virus infections and interferon-alpha on porphyrin profiles in plasma, urine and faeces. J Gastroenterol Hepatol 2000; 15:192-201.